Evercore ISI raised the firm’s price target on Intuitive Surgical to $425 from $385 and keeps an In Line rating on the shares in an earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical price target raised to $451 from $421 at BTIG
- Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
- Intuitive Surgical announces FDA clearance of revised da Vinci Xi, X labeling
- PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls
- Intuitive Surgical initiated with a Buy at Goldman Sachs